Table 1 Characterization of acetylthevetin B (ATB)-based formulations. Mean±SD. n=3.

From: Delivery of acetylthevetin B, an antitumor cardiac glycoside, using polymeric micelles for enhanced therapeutic efficacy against lung cancer cells

Formulations

Particle size (nm)

Zeta potential (mV)

EE%

ATB-CP1

50.69±3.12

−2.50±1.82

93.8±0.25

ATB-CP2

39.91±5.27

−7.36±3.81

90.1±0.21

Back to article page